Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Menopause | 38 | 2020 | 95 | 9.320 |
Why?
|
Breast Neoplasms | 34 | 2020 | 765 | 8.360 |
Why?
|
Quality of Life | 37 | 2020 | 946 | 7.790 |
Why?
|
Hot Flashes | 22 | 2020 | 48 | 5.420 |
Why?
|
Women's Health | 28 | 2021 | 235 | 4.370 |
Why?
|
Survivors | 12 | 2018 | 163 | 3.160 |
Why?
|
Acupuncture Therapy | 6 | 2019 | 19 | 2.720 |
Why?
|
Adaptation, Psychological | 8 | 2017 | 138 | 2.610 |
Why?
|
Middle Aged | 85 | 2021 | 11839 | 2.380 |
Why?
|
Depression | 17 | 2018 | 445 | 2.180 |
Why?
|
Perimenopause | 8 | 2021 | 13 | 2.170 |
Why?
|
Female | 97 | 2021 | 20015 | 2.080 |
Why?
|
Health Status | 8 | 2019 | 400 | 2.080 |
Why?
|
Longitudinal Studies | 30 | 2020 | 770 | 1.910 |
Why?
|
Sexual Behavior | 6 | 2018 | 120 | 1.890 |
Why?
|
Yoga | 5 | 2019 | 50 | 1.780 |
Why?
|
Humans | 102 | 2021 | 32114 | 1.660 |
Why?
|
Vasomotor System | 10 | 2021 | 22 | 1.640 |
Why?
|
Adult | 61 | 2021 | 9380 | 1.630 |
Why?
|
Ethnic Groups | 12 | 2019 | 476 | 1.620 |
Why?
|
Sexuality | 4 | 2017 | 12 | 1.430 |
Why?
|
Sweating | 10 | 2020 | 15 | 1.380 |
Why?
|
Premenopause | 7 | 2018 | 44 | 1.150 |
Why?
|
Aging | 9 | 2020 | 946 | 1.130 |
Why?
|
Exercise | 4 | 2020 | 673 | 1.100 |
Why?
|
Sickness Impact Profile | 4 | 2014 | 35 | 1.070 |
Why?
|
Stress, Psychological | 8 | 2018 | 221 | 1.040 |
Why?
|
Body Mass Index | 8 | 2020 | 923 | 1.030 |
Why?
|
Social Support | 7 | 2017 | 182 | 1.010 |
Why?
|
Postmenopause | 8 | 2017 | 430 | 0.980 |
Why?
|
Aged | 29 | 2020 | 10314 | 0.970 |
Why?
|
Attitude to Health | 6 | 2009 | 166 | 0.950 |
Why?
|
United States | 33 | 2021 | 3976 | 0.870 |
Why?
|
Psychometrics | 4 | 2015 | 137 | 0.870 |
Why?
|
Cross-Sectional Studies | 16 | 2020 | 1542 | 0.830 |
Why?
|
Spirituality | 3 | 2018 | 37 | 0.810 |
Why?
|
Anxiety | 9 | 2018 | 191 | 0.780 |
Why?
|
Multivariate Analysis | 11 | 2018 | 684 | 0.740 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2018 | 12 | 0.730 |
Why?
|
Colorectal Neoplasms | 3 | 2020 | 215 | 0.710 |
Why?
|
African Americans | 7 | 2017 | 1425 | 0.700 |
Why?
|
Risk Factors | 19 | 2020 | 3880 | 0.660 |
Why?
|
Patient Participation | 2 | 2012 | 82 | 0.650 |
Why?
|
Logistic Models | 11 | 2020 | 783 | 0.640 |
Why?
|
Age Factors | 11 | 2020 | 1189 | 0.640 |
Why?
|
Patient Satisfaction | 2 | 2017 | 240 | 0.640 |
Why?
|
Time Factors | 11 | 2019 | 2151 | 0.610 |
Why?
|
Neoplasms | 4 | 2019 | 728 | 0.600 |
Why?
|
Mental Health | 5 | 2020 | 119 | 0.600 |
Why?
|
Cohort Studies | 11 | 2020 | 1817 | 0.590 |
Why?
|
Mammaplasty | 1 | 2017 | 26 | 0.590 |
Why?
|
Socioeconomic Factors | 10 | 2018 | 429 | 0.590 |
Why?
|
Breast | 1 | 2018 | 68 | 0.580 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2017 | 10 | 0.570 |
Why?
|
Waist Circumference | 1 | 2017 | 90 | 0.560 |
Why?
|
Educational Status | 7 | 2019 | 181 | 0.560 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 96 | 0.540 |
Why?
|
Mastectomy | 4 | 2017 | 64 | 0.540 |
Why?
|
Estradiol | 6 | 2021 | 136 | 0.540 |
Why?
|
Health Behavior | 2 | 2017 | 236 | 0.530 |
Why?
|
Smoking | 6 | 2019 | 528 | 0.520 |
Why?
|
Models, Theoretical | 1 | 2016 | 137 | 0.510 |
Why?
|
Prostatic Neoplasms | 3 | 2020 | 471 | 0.500 |
Why?
|
Workplace | 1 | 2015 | 50 | 0.500 |
Why?
|
Cross-Cultural Comparison | 5 | 2016 | 26 | 0.500 |
Why?
|
Body Weight | 1 | 2017 | 310 | 0.490 |
Why?
|
Libido | 3 | 2015 | 3 | 0.480 |
Why?
|
Decision Making | 3 | 2012 | 195 | 0.430 |
Why?
|
Aged, 80 and over | 10 | 2020 | 3990 | 0.430 |
Why?
|
Follow-Up Studies | 9 | 2018 | 2265 | 0.420 |
Why?
|
Ovariectomy | 2 | 2017 | 166 | 0.410 |
Why?
|
Women | 2 | 2009 | 12 | 0.400 |
Why?
|
Health Surveys | 7 | 2009 | 198 | 0.380 |
Why?
|
Estrogen Replacement Therapy | 5 | 2019 | 199 | 0.380 |
Why?
|
Prospective Studies | 8 | 2020 | 2283 | 0.370 |
Why?
|
European Continental Ancestry Group | 10 | 2017 | 1166 | 0.370 |
Why?
|
Asian Americans | 6 | 2017 | 97 | 0.370 |
Why?
|
Health Status Indicators | 2 | 2015 | 73 | 0.360 |
Why?
|
Cardiovascular Diseases | 4 | 2020 | 1128 | 0.340 |
Why?
|
Hispanic Americans | 8 | 2017 | 940 | 0.330 |
Why?
|
Follicle Stimulating Hormone | 4 | 2021 | 28 | 0.330 |
Why?
|
Testosterone | 4 | 2018 | 48 | 0.330 |
Why?
|
Markov Chains | 2 | 2020 | 29 | 0.320 |
Why?
|
Hypnosis | 1 | 2008 | 4 | 0.320 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2008 | 42 | 0.320 |
Why?
|
Dyspareunia | 3 | 2018 | 7 | 0.310 |
Why?
|
Continental Population Groups | 4 | 2019 | 237 | 0.310 |
Why?
|
Prevalence | 8 | 2018 | 989 | 0.300 |
Why?
|
Pain | 3 | 2018 | 288 | 0.280 |
Why?
|
Treatment Outcome | 5 | 2017 | 3306 | 0.280 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2006 | 7 | 0.270 |
Why?
|
Life Change Events | 3 | 2013 | 21 | 0.270 |
Why?
|
Vulvar Diseases | 1 | 2006 | 4 | 0.270 |
Why?
|
Informed Consent | 1 | 2006 | 34 | 0.260 |
Why?
|
Mental Disorders | 1 | 2007 | 124 | 0.260 |
Why?
|
Pelvic Pain | 1 | 2006 | 18 | 0.260 |
Why?
|
Menopause, Premature | 3 | 2018 | 9 | 0.250 |
Why?
|
Pilot Projects | 3 | 2016 | 548 | 0.250 |
Why?
|
Cognition | 5 | 2019 | 556 | 0.240 |
Why?
|
Mammography | 1 | 2004 | 41 | 0.240 |
Why?
|
Emotions | 2 | 2018 | 58 | 0.240 |
Why?
|
Video Recording | 1 | 2004 | 59 | 0.240 |
Why?
|
Cultural Diversity | 1 | 2004 | 22 | 0.240 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 301 | 0.230 |
Why?
|
Self Concept | 1 | 2004 | 43 | 0.230 |
Why?
|
Interpersonal Relations | 3 | 2013 | 57 | 0.230 |
Why?
|
Patient Acceptance of Health Care | 2 | 2008 | 172 | 0.220 |
Why?
|
Marital Status | 4 | 2018 | 23 | 0.220 |
Why?
|
Menarche | 2 | 2020 | 4 | 0.220 |
Why?
|
Male | 11 | 2020 | 19217 | 0.210 |
Why?
|
Japan | 4 | 2017 | 17 | 0.210 |
Why?
|
Masturbation | 2 | 2015 | 2 | 0.210 |
Why?
|
China | 4 | 2017 | 50 | 0.210 |
Why?
|
Affect | 3 | 2021 | 70 | 0.200 |
Why?
|
Cognition Disorders | 2 | 2019 | 385 | 0.200 |
Why?
|
Patient Education as Topic | 2 | 2020 | 272 | 0.200 |
Why?
|
Life Style | 7 | 2016 | 408 | 0.200 |
Why?
|
Registries | 2 | 2013 | 298 | 0.190 |
Why?
|
Severity of Illness Index | 4 | 2014 | 881 | 0.190 |
Why?
|
Pregnanediol | 1 | 2021 | 1 | 0.190 |
Why?
|
Climacteric | 3 | 2007 | 6 | 0.190 |
Why?
|
Luteinizing Hormone | 1 | 2021 | 22 | 0.190 |
Why?
|
Role | 2 | 2012 | 5 | 0.190 |
Why?
|
Dehydroepiandrosterone Sulfate | 3 | 2018 | 8 | 0.190 |
Why?
|
Analysis of Variance | 2 | 2018 | 464 | 0.180 |
Why?
|
Chronic Disease | 3 | 2016 | 406 | 0.180 |
Why?
|
Progesterone | 1 | 2021 | 101 | 0.180 |
Why?
|
Prognosis | 2 | 2020 | 1497 | 0.180 |
Why?
|
Vaginal Diseases | 2 | 2018 | 7 | 0.180 |
Why?
|
Hysterectomy | 2 | 2018 | 46 | 0.180 |
Why?
|
Karnofsky Performance Status | 1 | 2020 | 11 | 0.180 |
Why?
|
Biomedical Research | 2 | 2013 | 156 | 0.180 |
Why?
|
Psychology | 2 | 2013 | 24 | 0.180 |
Why?
|
Activities of Daily Living | 2 | 2013 | 257 | 0.180 |
Why?
|
Case-Control Studies | 2 | 2020 | 898 | 0.180 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2020 | 51 | 0.180 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2015 | 97 | 0.180 |
Why?
|
Peripheral Nerves | 1 | 2020 | 62 | 0.170 |
Why?
|
Incidence | 5 | 2020 | 1199 | 0.170 |
Why?
|
Needs Assessment | 1 | 2020 | 76 | 0.170 |
Why?
|
Patient Compliance | 2 | 2016 | 225 | 0.170 |
Why?
|
Australia | 4 | 2020 | 72 | 0.170 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 81 | 0.170 |
Why?
|
Regression Analysis | 2 | 2012 | 293 | 0.160 |
Why?
|
Cranial Irradiation | 1 | 2019 | 93 | 0.160 |
Why?
|
Premenstrual Syndrome | 1 | 2018 | 3 | 0.160 |
Why?
|
Ovarian Diseases | 1 | 2018 | 8 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 510 | 0.160 |
Why?
|
Demography | 1 | 2018 | 110 | 0.160 |
Why?
|
Antineoplastic Agents | 3 | 2016 | 608 | 0.160 |
Why?
|
Accidental Falls | 1 | 2020 | 222 | 0.160 |
Why?
|
Urinary Incontinence | 1 | 2018 | 47 | 0.150 |
Why?
|
Pain Measurement | 3 | 2016 | 350 | 0.150 |
Why?
|
Beauty | 1 | 2017 | 5 | 0.150 |
Why?
|
Odds Ratio | 4 | 2020 | 472 | 0.150 |
Why?
|
Sleep | 2 | 2016 | 92 | 0.150 |
Why?
|
Proportional Hazards Models | 4 | 2020 | 753 | 0.130 |
Why?
|
Smoking Cessation | 1 | 2018 | 210 | 0.130 |
Why?
|
Hormone Replacement Therapy | 3 | 2018 | 91 | 0.130 |
Why?
|
Disease Progression | 1 | 2018 | 594 | 0.130 |
Why?
|
Probability | 2 | 2007 | 159 | 0.130 |
Why?
|
Models, Biological | 1 | 2018 | 392 | 0.130 |
Why?
|
Social Perception | 1 | 2015 | 24 | 0.130 |
Why?
|
Cost of Illness | 1 | 2015 | 70 | 0.130 |
Why?
|
Menstruation | 1 | 2015 | 5 | 0.130 |
Why?
|
Hyperhidrosis | 2 | 2020 | 5 | 0.130 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2016 | 47 | 0.130 |
Why?
|
Obesity | 2 | 2020 | 1176 | 0.130 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2015 | 14 | 0.120 |
Why?
|
Neoplasm Staging | 2 | 2007 | 447 | 0.120 |
Why?
|
Social Adjustment | 1 | 2014 | 9 | 0.120 |
Why?
|
Data Collection | 2 | 2006 | 182 | 0.120 |
Why?
|
Linear Models | 2 | 2013 | 449 | 0.120 |
Why?
|
Cytokines | 1 | 2016 | 256 | 0.120 |
Why?
|
Depressive Disorder | 2 | 2012 | 75 | 0.120 |
Why?
|
Combined Modality Therapy | 2 | 2007 | 560 | 0.120 |
Why?
|
Alcohol Drinking | 1 | 2017 | 255 | 0.120 |
Why?
|
Behavioral Sciences | 1 | 2013 | 1 | 0.110 |
Why?
|
Asian Continental Ancestry Group | 3 | 2016 | 108 | 0.110 |
Why?
|
Pain, Postoperative | 1 | 2016 | 178 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 458 | 0.110 |
Why?
|
Information Dissemination | 1 | 2013 | 52 | 0.110 |
Why?
|
Leukemia | 1 | 2013 | 40 | 0.110 |
Why?
|
Lymphoma | 1 | 2013 | 35 | 0.110 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 412 | 0.110 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2013 | 74 | 0.110 |
Why?
|
Anthracyclines | 1 | 2013 | 62 | 0.100 |
Why?
|
Syndrome | 2 | 2018 | 72 | 0.100 |
Why?
|
Patient Preference | 1 | 2012 | 47 | 0.100 |
Why?
|
Databases, Factual | 1 | 2013 | 355 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2012 | 185 | 0.100 |
Why?
|
Age of Onset | 2 | 2018 | 94 | 0.100 |
Why?
|
Reward | 1 | 2012 | 64 | 0.100 |
Why?
|
Risk Assessment | 3 | 2019 | 1429 | 0.100 |
Why?
|
African Continental Ancestry Group | 3 | 2016 | 363 | 0.090 |
Why?
|
Neuropsychological Tests | 2 | 2009 | 371 | 0.090 |
Why?
|
Population Surveillance | 2 | 2008 | 125 | 0.090 |
Why?
|
Endocrine Glands | 1 | 2010 | 2 | 0.090 |
Why?
|
Computational Biology | 1 | 2010 | 91 | 0.090 |
Why?
|
Public Health | 1 | 2010 | 89 | 0.080 |
Why?
|
Mental Processes | 1 | 2009 | 17 | 0.080 |
Why?
|
Social Behavior | 1 | 2009 | 65 | 0.080 |
Why?
|
Placebo Effect | 1 | 2008 | 14 | 0.080 |
Why?
|
Myocardial Infarction | 2 | 2020 | 475 | 0.080 |
Why?
|
Young Adult | 2 | 2013 | 2665 | 0.080 |
Why?
|
Affective Symptoms | 1 | 2008 | 16 | 0.080 |
Why?
|
Research Design | 2 | 2010 | 315 | 0.080 |
Why?
|
Estrogens | 1 | 2010 | 180 | 0.080 |
Why?
|
Europe | 2 | 2018 | 82 | 0.080 |
Why?
|
Palliative Care | 1 | 2008 | 52 | 0.080 |
Why?
|
North Carolina | 1 | 2012 | 1538 | 0.070 |
Why?
|
Risk | 2 | 2020 | 321 | 0.070 |
Why?
|
Survival Rate | 2 | 2007 | 877 | 0.070 |
Why?
|
New Hampshire | 1 | 2006 | 5 | 0.070 |
Why?
|
Boston | 1 | 2006 | 15 | 0.070 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 55 | 0.070 |
Why?
|
Biopsy, Needle | 1 | 2007 | 93 | 0.070 |
Why?
|
Retrospective Studies | 2 | 2012 | 3510 | 0.070 |
Why?
|
Travel | 1 | 2006 | 15 | 0.070 |
Why?
|
New Jersey | 1 | 2006 | 9 | 0.070 |
Why?
|
Happiness | 1 | 2005 | 3 | 0.060 |
Why?
|
Contraception | 1 | 2005 | 13 | 0.060 |
Why?
|
Shock, Cardiogenic | 1 | 2005 | 10 | 0.060 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 41 | 0.060 |
Why?
|
Perception | 1 | 2006 | 101 | 0.060 |
Why?
|
Florida | 1 | 2005 | 37 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2007 | 538 | 0.060 |
Why?
|
Vagina | 1 | 2005 | 59 | 0.060 |
Why?
|
Pamphlets | 1 | 2004 | 5 | 0.060 |
Why?
|
Patient Selection | 1 | 2006 | 276 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2006 | 185 | 0.060 |
Why?
|
Stroke | 2 | 2020 | 585 | 0.060 |
Why?
|
Age Distribution | 1 | 2004 | 206 | 0.060 |
Why?
|
Sex Factors | 1 | 2006 | 667 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2006 | 367 | 0.060 |
Why?
|
Education | 1 | 2003 | 38 | 0.060 |
Why?
|
Adolescent | 2 | 2016 | 3568 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2018 | 297 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2013 | 19 | 0.050 |
Why?
|
Comorbidity | 2 | 2018 | 566 | 0.050 |
Why?
|
Mass Screening | 1 | 2004 | 263 | 0.050 |
Why?
|
Child | 2 | 2020 | 2442 | 0.050 |
Why?
|
Angina Pectoris | 1 | 2020 | 22 | 0.050 |
Why?
|
Appalachian Region | 1 | 2020 | 17 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 765 | 0.040 |
Why?
|
Vulnerable Populations | 1 | 2020 | 34 | 0.040 |
Why?
|
Recurrence | 1 | 2020 | 263 | 0.040 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 101 | 0.040 |
Why?
|
Fatigue | 1 | 2019 | 85 | 0.040 |
Why?
|
Coitus | 1 | 2018 | 2 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2020 | 147 | 0.040 |
Why?
|
Coronary Disease | 1 | 2019 | 211 | 0.040 |
Why?
|
Thinness | 1 | 2018 | 33 | 0.040 |
Why?
|
Rural Population | 1 | 2020 | 277 | 0.040 |
Why?
|
Memory | 2 | 2010 | 190 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2018 | 109 | 0.040 |
Why?
|
Middle East | 1 | 2016 | 5 | 0.030 |
Why?
|
Latin America | 1 | 2016 | 9 | 0.030 |
Why?
|
Genital Neoplasms, Female | 1 | 2016 | 17 | 0.030 |
Why?
|
Patient Care Management | 1 | 2016 | 18 | 0.030 |
Why?
|
Overweight | 1 | 2018 | 280 | 0.030 |
Why?
|
Meditation | 1 | 2016 | 22 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 77 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2015 | 125 | 0.030 |
Why?
|
Checklist | 1 | 2015 | 38 | 0.030 |
Why?
|
Computer Security | 1 | 2013 | 7 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2013 | 22 | 0.030 |
Why?
|
Medical Informatics | 1 | 2013 | 27 | 0.030 |
Why?
|
Irritable Mood | 1 | 2013 | 5 | 0.030 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 23 | 0.030 |
Why?
|
Troponin I | 1 | 2013 | 22 | 0.030 |
Why?
|
Comprehensive Health Care | 1 | 2013 | 5 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2013 | 66 | 0.030 |
Why?
|
International Cooperation | 1 | 2013 | 28 | 0.030 |
Why?
|
Fear | 1 | 2013 | 48 | 0.030 |
Why?
|
Tamoxifen | 1 | 2012 | 59 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2013 | 44 | 0.030 |
Why?
|
Health Policy | 1 | 2013 | 89 | 0.030 |
Why?
|
Brain | 1 | 2019 | 951 | 0.030 |
Why?
|
Internet | 1 | 2013 | 198 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2013 | 245 | 0.020 |
Why?
|
Mothers | 1 | 2012 | 88 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 876 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 24 | 0.020 |
Why?
|
Psychological Tests | 1 | 2010 | 35 | 0.020 |
Why?
|
Stroke Volume | 1 | 2013 | 348 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2010 | 20 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2010 | 177 | 0.020 |
Why?
|
Sleep Disorders, Intrinsic | 1 | 2008 | 1 | 0.020 |
Why?
|
Selection Bias | 1 | 2008 | 13 | 0.020 |
Why?
|
Personality Inventory | 1 | 2007 | 18 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 582 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 1328 | 0.020 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2005 | 6 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2005 | 42 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2005 | 63 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 103 | 0.020 |
Why?
|
Recovery of Function | 1 | 2005 | 199 | 0.010 |
Why?
|
Survival Analysis | 1 | 2005 | 483 | 0.010 |
Why?
|